Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

That headline comes courtesy of a recent study out of Stanford Medicine, published in the journal Nature ... (The Stanford ...

Binzer died at his home in Los Angeles on June 24 from an accidental drug overdose, according to his manager ... that he was ...

Temple visits and short wedding trips aren’t enough — people are now solo travelling with an ageing parent to reconnect and ...

The Women's Guild Cedars-Sinai Enchanted Ball on November 21 will honor Lionel Richie and the Ochoas, featuring a performance ...

And when the candidates released their platforms, there would be a list of tech policy ideas to dissect ... neurodegenerative ...

This year's list reflects pharma's increasing ... (ABBV-951): Developed by AbbVie, the drug is a reformulation of a standard Parkinson's treatment (carbidopa/levodopa) delivered by subcutaneous ...

It’s that time of the week, folks. In this week’s mailbag, Stephen ‘Breadman’ Edwards casts his eyes over questions about ...

In a world where innovation and resilience redefine success, certain entrepreneurs stand out for their unmatched vision, ...

What’s more, the drugs are expensive, with list prices higher than $25,000 a year ... Does efficacy wane over time, that is, do you have to take higher doses (like with Parkinson’s drugs) to get the ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.